KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.90 $2.68 Friday, 26th Apr 2024 FGEN stock ended at $1.04. This is 1.96% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.67% from a day low at $0.98 to a day high of $1.06.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Mar 07, 2016 $19.51 $21.21 $18.91 $20.28 579 900
Mar 04, 2016 $18.72 $20.25 $18.45 $19.57 574 400
Mar 03, 2016 $18.43 $18.83 $18.04 $18.77 408 500
Mar 02, 2016 $17.97 $18.99 $17.72 $18.48 544 200
Mar 01, 2016 $17.57 $18.02 $15.78 $18.00 841 700
Feb 29, 2016 $18.61 $18.75 $17.21 $17.33 594 600
Feb 26, 2016 $18.33 $18.68 $17.90 $18.19 391 100
Feb 25, 2016 $18.87 $19.18 $18.03 $18.26 312 000
Feb 24, 2016 $17.89 $18.67 $17.21 $18.51 464 800
Feb 23, 2016 $19.33 $19.59 $17.90 $17.98 431 400
Feb 22, 2016 $19.90 $20.49 $19.28 $19.39 451 800
Feb 19, 2016 $19.54 $19.91 $18.64 $19.80 412 800
Feb 18, 2016 $20.00 $20.80 $19.24 $19.31 458 300
Feb 17, 2016 $18.99 $20.24 $18.75 $19.81 632 200
Feb 16, 2016 $18.20 $19.13 $17.92 $18.56 792 300
Feb 12, 2016 $17.33 $17.95 $16.61 $17.70 544 900
Feb 11, 2016 $15.58 $17.49 $14.96 $17.19 1 321 400
Feb 10, 2016 $15.46 $16.30 $15.02 $15.08 523 700
Feb 09, 2016 $14.86 $15.87 $14.39 $15.33 693 200
Feb 08, 2016 $16.54 $16.63 $14.38 $14.76 853 000
Feb 05, 2016 $17.36 $17.97 $16.48 $16.64 657 700
Feb 04, 2016 $17.94 $18.26 $17.20 $17.54 648 900
Feb 03, 2016 $18.60 $19.05 $17.31 $18.36 512 000
Feb 02, 2016 $19.20 $19.33 $18.35 $18.48 422 800
Feb 01, 2016 $20.17 $20.54 $19.22 $19.46 529 300
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT